Group One Trading
PVLA

Group One Trading’s Palvella Therapeutics PVLA Stock Holding History

Group One Trading’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$636K Buy
+5,100
New +$532K ﹤0.01% 3117
2025
Q3 		– Sell
-2,000
Closed -$45.1K – 9318
2025
Q2 		$45.1K Hold
2,000
– – ﹤0.01% 5664
2025
Q1 		$56K Buy
+2,000
New +$38.5K ﹤0.01% 5075
2024
Q1 		– Sell
-18
Closed -$255 – 8122
2023
Q4 		$255 Hold
18
– – ﹤0.01% 7150
2023
Q3 		$417 Hold
18
– – ﹤0.01% 7364
2023
Q2 		$232 Hold
18
– – ﹤0.01% 7459
2023
Q1 		$1.37K Sell
18
-63
-78% -$7.29K ﹤0.01% 6710
2022
Q4 		$6.76K Sell
81
-63
-44% -$5.06K ﹤0.01% 6208
2022
Q3 		$13K Hold
144
– – ﹤0.01% 6354
2022
Q2 		$22K Sell
144
-549
-79% -$100K ﹤0.01% 6231
2022
Q1 		$168K Sell
693
-308
-31% -$81K ﹤0.01% 4988
2021
Q4 		$303K Buy
1,001
+795
+386% +$255K ﹤0.01% 4649
2021
Q3 		$85K Sell
206
-2,659
-93% -$926K ﹤0.01% 6067
2021
Q2 		$878K Buy
2,865
+2,815
+5,630% +$617K ﹤0.01% 3569
2021
Q1 		$10K Buy
+50
New +$10.9K ﹤0.01% 7066
2020
Q1 		– Sell
-18
Closed -$5K – 5835
2019
Q4 		$5K Sell
18
-46
-72% -$12.8K ﹤0.01% 4758
2019
Q3 		$17K Buy
64
+51
+392% +$19.7K ﹤0.01% 4414
2019
Q2 		$5K Buy
+13
New +$3.88K ﹤0.01% 4615
2018
Q2 		– Sell
-139
Closed -$76K – 5551
2018
Q1 		$76K Buy
139
+94
+209% +$58.2K ﹤0.01% 3425
2017
Q4 		$27K Buy
+45
New +$20.9K ﹤0.01% 4040

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Group One Trading's PVLA Position: Q1 2026 in Review

Group One Trading sold out of Palvella Therapeutics (PVLA) in Q1 2026, closing a stake of 332 shares — an estimated $34.6K sold.

Group One Trading first reported a position in PVLA in Q2 2019 and held it in 22 quarters. The position peaked at $362K in Q3 2021. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Group One Trading reported no remaining Palvella Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 332 Palvella Therapeutics shares in Q1 2026, an estimated $34.6K.
  • Group One Trading first reported a position in Palvella Therapeutics in Q2 2019 and held it in 22 quarters.
  • Group One Trading's Palvella Therapeutics position peaked at $362K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.